Cardiology
News, opinions and meeting coverage in cardiology.
Latest in Cardiology
The risks and how to protect yourself
Device was recently approved for drug-refractory paroxysmal atrial fibrillation
Lower risk of all-cause and cardiovascular mortality observed only among morning drinkers
Device was recently approved for drug-refractory paroxysmal atrial fibrillation
Lower risk of all-cause and cardiovascular mortality observed only among morning drinkers
Cardiology Case Studies
ECG findings clarify those of a thorough physical and patient history

Symptom resolution after stopping anti-HER2 therapy suggests treatment-related cardiotoxicity

Idiopathic ventricular fibrillation can affect people with no clinical evidence of heart disease

More in Cardiology
Achieving remission and addressing CV risk factors made a big difference in Greek study

Macitentan/tadalafil and sotatercept approvals shifted the field, but by how much seems to differ
